Possibility of correction of cerebral blood flow disorders and central nervous system damage with citicoline in patients with coronary artery disease in combination with COVID-19-Reference-Cited by-同舟云学术

Possibility of correction of cerebral blood flow disorders and central nervous system damage with citicoline in patients with coronary artery disease in combination with COVID-19

Published:2024-03-27 Issue:1 Volume: Page:51-57
ISSN:2709-0957
Container-title:Infusion & Chemotherapy
language:
Short-container-title:IC

Author:

Netiazhenko V.Z.^ORCID,Mostovyi S.Ye.^ORCID

Abstract

ABSTRACT. The review describes some pathogenetic mechanisms of central nervous system lesions in patients with coronary artery disease in combination with coronavirus disease (COVID-19) and presents the current possibilities of their pharmacotherapy. The analysis of experimental and clinical trials has shown that the multifactorial effect of citicoline on the main pathogenic links of brain damage in COVID-19 and numerous positive clinical effects make it a promising drug in the treatment of patients with coronary artery disease in combination with COVID-19 and post-COVID syndrome.

Publisher

Communicable Diseases Intensive Care Association

Reference60 articles.

1. Singh S., Meher N., Mohammed A., et al. Neurological infection and complications of SARS-CoV-2: a review. Medicine (Baltimore). 2023; 102 (5): e30284. doi: 10.1097/MD.0000000000030284.

2. Heymann D.L., Shindo N. COVID-19: what is next for public health? The Lancet. 2020. doi: 10.1016/ S0140-6736(20)30374-3.

3. Huang C., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020; 395 (10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5.

4. Pezzini A., Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat. Rev. Neurol. 2020; 16 (11): 636. doi: 10.1038/s41582-020-0398-3.

5. Kanberg N., et al. Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19. Neurology. 2020; 95 (12): e1754. doi: 10.1212/wnl.0000000000010111.